A renal therapy system is disclosed. In an example, a renal therapy system includes a dialysis fluid pump, a control processor for controlling a treatment performed by the dialysis fluid pump, and a user interface device in operable communication with the control processor.

A clamping device capable of clamping a flexible tube in a good manner without fail and also capable of intercepting the flow of a fluid in the flexible tube more exactly. A clamping device includes a one end portion having a locked part at a tip, an other end portion having a locking part capable of locking the locked part, and insertion holes allowing a flexible tube to be inserted between a first projection and a second projection. In a clamped state, the first projection and the second projection are positioned close to each other, and the flexible tube is thus clamped so that the flow of a fluid is intercepted at the clamped position. The other end portion has interfering parts. When the one end portion is further pressed with the locked part being locked by the locking part, the interfering parts interfere with predetermined points and prevents further movement of the locked part.

A dialysis system (10) comprising a dialysis machine (20) and a water purification system (30). The water purification system (30) comprising a pre-treatment system (10) and a primary treatment system (80). The water purification system (30) is provided within a portable unit (90) defining an enclosure. The dialysis machine (20) is removably provided on an upper surface of the enclosure of the portable unit (90).

The present disclosure provides a method of removing a target substance from blood of a patient, the method comprising steps of: providing a complexing agent, especially a supra-molecular compound or core particle, adapted for selectively binding a target molecule or target entity in the blood of the patient in a complex, e.g. a supra-molecular complex; administering the complexing agent into the patient's blood, preferably into an extracorporeal blood flow pathway, for binding with the target molecule or the target entity; conveying the blood having the complexing agent through a treatment zone of an extracorporeal blood flow pathway for a predetermined period of time to bind or incorporate the target molecule or target entity within the blood in a complex, such as a supra-molecular complex; and removing the complex (e.g. supra-molecular complex) from the blood by haemodialysis, which preferably includes one or more of filtration, ultrafiltration, convection, or adsorption. The disclosure thus also provides a system (1) for removing a target substance from blood of a patient, the system (1) comprising: an extracorporeal blood flow pathway (2) for connection to a patient and for guiding or conveying a flow of blood from the patient along the pathway; a treatment zone (5) arranged in the extracorporeal blood flow pathway (2) for mixing a complexing agent (C) with the blood adapted to bind a target molecule (M) in a complex (X), especially a supra-molecular complex or core particle complex, as the blood flows through the treatment zone (5); and a haemodialysis unit (4) for separating the complex (X) from the blood via one or more of filtration, ultra-filtration, convection, and membrane adsorption, with or without magnetic assistance.

The present disclosure provides compositions and methods for treating cancer with nutritionally modified diets and/or dialysis treatment, such as through amino acid depletion of one or more nonessential amino acids. In some aspects, the present disclosure provides compositions and methods for treating obesity with such modified diets and/or dialysis treatment. Furthermore, in some aspects, the present disclosure provides compositions and methods for treating renal disease with such modified diets and/or dialysis treatment.

The invention relates to a dialysis machine having an extracorporeal blood circuit, a blood pump, a dialyzer, a venous pressure sensor, a substituate line, and a control unit, wherein the control unit is configured to operate the blood pump in a first operating mode and in a special operating mode and to start the special operating mode after recognition of a trigger event, in which special operating mode a conveying rate of the blood pump is controlled by means of a default value or is regulated to a desired value, which default or desired value is derived from a value determined before the start of the currently started special operating mode or corresponds to said value, wherein the presence of at least one obstacle is polled before the start of the special operating mode, and wherein, on the presence of the obstacle, the start of the special operating mode is blocked or delayed and/or the selection of the default value or of the desire value on the presence of the obstacle differs from the selection without the presence of the obstacle.

Disclosed are methods of administering cephalosporin/tazobactam to human patients with end stage renal disease undergoing hemodialysis and suffering from a complicated intra-abdominal infection or a complicated urinary tract infection.

Disclosed are methods of administering cephalosporin/tazobactam to human patients with end stage renal disease undergoing hemodialysis and suffering from a complicated intra-abdominal infection or a complicated urinary tract infection.

A blood purification apparatus includes a blood circuit, a dialyzer capable of purifying the blood flowing through the blood circuit, a blood pump provided to an arterial blood circuit and that delivers the blood in the blood circuit, and an air-trap chamber capable of collecting air in the blood flowing through the blood circuit. A peristaltic pump (a substitution-fluid-infusion device) that is capable of infusing a substitution fluid is connected to the air-trap chamber. A substitution fluid layer is formable on a blood layer in the air-trap chamber. The air-trap chamber is provided with a blood-interface-detecting device that is capable of detecting an interface between the blood layer and the substitution fluid layer that are formed in the air-trap chamber. A lack of substitution fluid in the air-trap chamber is detectable on the basis of the interface between the blood layer and the substitution fluid layer that is detected by the blood-interface-detecting device.

An article configured to warm and monitor a patient during a dialysis treatment, the article includes one or more heating elements. The article also includes one or more sensors configured to monitor a condition of the patient during the dialysis treatment. The article also includes a fabric portion configured to receive the one or more heating elements and the one or more sensors and position the one or more heating elements and the one or more sensors on the patient during treatment. The article also includes a transmitter configured to transmit information from the one or more sensors to a dialysis machine and an electrical connector configured to provide power to at least one of the one or more heating elements and the one or more sensors.